title: p16(INK4A) positively regulates p21(WAF1) expression by suppressing AUF1-dependent mRNA decay.
abstract: BACKGROUND
  p16(INK4a) and p21(WAF1) are two independent cyclin-dependent kinase inhibitors encoded by the CDKN2A and CDKN1A genes, respectively. p16(INK4a) and p21(WAF1) are similarly involved in various anti-cancer processes, including the regulation of the critical G1 to S phase transition of the cell cycle, senescence and apoptosis. Therefore, we sought to elucidate the molecular mechanisms underlying the link between these two important tumor suppressor proteins.
  
  
  RESULTS
  We have shown here that the p16(INK4a) protein positively controls the expression of p21(WAF1) in both human and mouse cells. p16(INK4a) stabilizes the CDKN1A mRNA through negative regulation of the mRNA decay-promoting AUF1 protein. Immunoprecipitation of AUF1-associated RNAs followed by quantitative RT-PCR indicated that endogenous AUF1 binds to the CDKN1A mRNA in a p16(INK4A)-dependent manner. Furthermore, while AUF1 down-regulation increased the expression level of the CDKN1A mRNA, the concurrent knockdown of AUF1 and CDKN2A, using specific silencing RNAs, restored the normal expression of the gene. Moreover, we used EGFP reporter fused to the CDKN2A AU-rich element (ARE) to demonstrate that p16(INK4A) regulation of the CDKN1A mRNA is AUF1- and ARE-dependent. Furthermore, ectopic expression of p16(INK4A) in p16(INK4A)-deficient breast epithelial MCF-10A cells significantly increased the level of p21(WAF1), with no effect on cell proliferation. In addition, we have shown direct correlation between p16(INK4a) and p21(WAF1) levels in various cancer cell lines.
  
  
  CONCLUSIONS
  These findings show that p16(INK4a) stabilizes the CDKN1A mRNA in an AUF1-dependent manner, and further confirm the presence of a direct link between the 2 important cancer-related pathways, pRB/p16(INK4A) and p14(ARF)/p53/p21(WAF1).
authors.affiliation: Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
authors.forename: Huda H
authors.initials: HH
authors.lastname: Al-Khalaf
authors.forename: Abdelilah
authors.initials: A
authors.lastname: Aboussekhra
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000378:metabolism*; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000235:genetics*; D004622:Embryo, Mammalian / Q000166:cytology; D005347:Fibroblasts / Q000378:metabolism; D005786:Gene Expression Regulation; D000081035:Heterogeneous Nuclear Ribonucleoprotein D0; D034502:Heterogeneous-Nuclear Ribonucleoprotein D / Q000378:metabolism; D006801:Humans; D051379:Mice; D012323:RNA Processing, Post-Transcriptional; D020871:RNA Stability; D015398:Signal Transduction
chemical_list: C493956:CDKN1A protein, human; C493957:Cdkn1a protein, mouse; D019941:Cyclin-Dependent Kinase Inhibitor p16; D050759:Cyclin-Dependent Kinase Inhibitor p21; C000630986:HNRNPD protein, human; D000081035:Heterogeneous Nuclear Ribonucleoprotein D0; D034502:Heterogeneous-Nuclear Ribonucleoprotein D; C000630987:Hnrpd protein, mouse
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4510-5
references.pmid: 11274368
references.citation: Nature. 1993 Dec 16;366(6456):704-7
references.pmid: 8259215
references.citation: Gene. 1999 Mar 18;229(1-2):223-8
references.pmid: 10095122
references.citation: Genomics. 1994 Sep 1;23(1):265-8
references.pmid: 7829086
references.citation: Oncogene. 1998 Dec 31;17(26):3463-9
references.pmid: 10030670
references.citation: Semin Cancer Biol. 2001 Jun;11(3):201-18
references.pmid: 11407945
references.citation: Nature. 2001 Sep 6;413(6851):83-6
references.pmid: 11544530
references.citation: Mol Cell Biol. 1999 Mar;19(3):1981-9
references.pmid: 10022885
references.citation: Oncogene. 2004 Jan 8;23(1):201-12
references.pmid: 14712225
references.citation: Cancer Causes Control. 2007 Dec;18(10):1187-98
references.pmid: 17823850
references.citation: Nature. 2001 Sep 6;413(6851):86-91
references.pmid: 11544531
references.citation: Nucleic Acids Res. 2007;35(1):223-33
references.pmid: 17158160
references.citation: Oncogene. 2013 May 2;32(18):2356-64
references.pmid: 22751126
references.citation: EMBO J. 2004 Aug 4;23(15):3092-102
references.pmid: 15257295
references.citation: Biochim Biophys Acta. 2002 Mar 14;1602(1):73-87
references.pmid: 11960696
references.citation: Biochim Biophys Acta. 1998 Oct 14;1378(2):F115-77
references.pmid: 9823374
references.citation: PLoS One. 2011;6(7):e21111
references.pmid: 21799732
references.citation: Int J Dev Biol. 2011;55(7-9):841-9
references.pmid: 22161840
references.citation: EMBO Rep. 2005 Feb;6(2):158-64
references.pmid: 15678155
references.citation: Mol Cell Biol. 1999 May;19(5):3916-28
references.pmid: 10207115
references.citation: Mol Cell Biol. 1999 Apr;19(4):3103-14
references.pmid: 10082577
references.citation: Cancer Lett. 2002 May 8;179(1):1-14
references.pmid: 11880176
references.citation: Leuk Res. 2005 Nov;29(11):1237-8
references.pmid: 15946739
references.citation: Nat Med. 2004 Aug;10(8):789-99
references.pmid: 15286780
references.citation: Mol Cancer Ther. 2006 Jun;5(6):1385-6
references.pmid: 16818495
references.citation: Nat Rev Cancer. 2006 Jan;6(1):11-23
references.pmid: 16372018
references.citation: Mol Cell Biol. 1999 Mar;19(3):1775-83
references.pmid: 10022865
references.citation: Cell. 1993 May 7;73(3):487-97
references.pmid: 8343202
references.citation: Nat Struct Mol Biol. 2007 Jun;14(6):511-8
references.pmid: 17486099
references.citation: Genes Dev. 2000 Nov 1;14(21):2745-56
references.pmid: 11069891
references.citation: Hepatol Res. 2001 May 1;20(1):52-67
references.pmid: 11282486
references.citation: Nucleic Acids Res. 2012 Sep;40(16):7739-52
references.pmid: 22718976
references.citation: Cancer Res. 2008 Apr 15;68(8):2717-25
references.pmid: 18413739
references.citation: Oncogene. 1999 Sep 23;18(39):5403-12
references.pmid: 10498894
references.citation: Biofactors. 2009 Mar-Apr;35(2):161-4
references.pmid: 19449443
references.citation: Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14590-5
references.pmid: 9405657
references.citation: EMBO J. 1999 Mar 15;18(6):1571-83
references.pmid: 10075928
references.citation: Cancer Res. 1994 Nov 1;54(21):5547-51
references.pmid: 7923195
references.citation: Biochemistry. 2011 Jun 28;50(25):5566-82
references.pmid: 21619050
references.citation: Oncogene. 2006 Jul 6;25(29):4128-32
references.pmid: 16462758
references.citation: Oncogene. 2005 Apr 18;24(17):2787-95
references.pmid: 15838515